09/05/2024
10:31 AM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
9:42 AM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
5:29 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
4:40 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
4:42 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
4:07 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
4:33 PM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
07/02/2024
4:31 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
4:32 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
4:32 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
3:37 PM | Cumberland Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
4:14 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
7:22 PM | Cumberland Pharmaceuticals (Issuer)
Hamm John M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:24 PM | Anthony Todd M. (Reporting)
Cumberland Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:25 PM | Bitterman Chris T. (Reporting)
Cumberland Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:26 PM | Cumberland Pharmaceuticals (Issuer)
Herman James L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:28 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:29 PM | Brown Martin S JR (Reporting)
Cumberland Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:31 PM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:31 PM | Cumberland Pharmaceuticals (Issuer)
Galante Joseph C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:32 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:33 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
4:15 PM | Cumberland Pharmaceuticals (Filer)
| Form 424B5 | |
03/20/2024
4:20 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
4:03 PM | Cumberland Pharmaceuticals (Filer)
| Form DEF 14A | |
03/13/2024
4:04 PM | Cumberland Pharmaceuticals (Filer)
| Form DEFA14A | |
03/05/2024
4:10 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
4:27 PM | Cumberland Pharmaceuticals (Subject)
| Form SC 13G | |
12/28/2023
4:07 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:08 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:10 PM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:11 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
11:15 PM | Cumberland Pharmaceuticals (Filer)
| Form EFFECT | |
12/14/2023
4:09 PM | Cumberland Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/06/2023
4:01 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4/A | |
12/06/2023
4:02 PM | Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
4:03 PM | Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
4:04 PM | Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
4:05 PM | Cumberland Pharmaceuticals (Issuer)
Hamm John M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
7:15 AM | Cumberland Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
4:21 PM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The $15 Stock Powering NVIDIA, TESLA and Microsoft (Ad) The Biggest AI firms in the world...Tesla... Microsoft... NVIDIA...
Are all relying on a little-known supplier, which provides a crucial building block for AI. Click here for the ticker >>> |
10/17/2023
4:04 PM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/13/2023
8:11 AM | Cumberland Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2023
8:24 AM | Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
